Title

A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.

Document Type

Journal Article

Publication Date

7-11-2017

Journal

Leukemia & Lymphoma

DOI

10.1080/10428194.2017.1347932

Peer Reviewed

1